Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
Latest press releases and news stories
Go to news archive
Featured News Article
23/03/2026
News story
AAD 2026: Galderma’s scientific presentations
23/03/2026
Press release
Galderma receives U.S. FDA approval for Restylane® Contour™ for the correction of temple hollowing
20/03/2026
Press release
Galderma publishes invitation and agenda for its 2026 Annual General Meeting
17/03/2026
Press release
AMWC 2026: Galderma showcases category‑leading innovation with a comprehensive portfolio and holistic, future‑focused aesthetic strategies
17/03/2026
News story
AMWC Monaco 2026: Galderma’s scientific presentations and activities
11/03/2026
Press release
Galderma buys back shares worth CHF 232 million in the context of accelerated bookbuild offering
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
25.08.2025
Press release
17.06.2025
Press release
